• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    23.22 Down 0.10(0.43%) Jan 30, 4:00PM EST
    |After Hours : 23.22 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:23.32
    Open:23.16
    Bid:21.86 x 500
    Ask:N/A
    1y Target Est:34.75
    Beta:-0.25
    Earnings Date:Feb 24 - Mar 2 (Est.)
    Day's Range:23.05 - 23.98
    52wk Range:19.10 - 68.76
    Volume:723,284
    Avg Vol (3m):1,171,240
    Market Cap:660.26M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 0.43%660.26M
    AZNDown 1.18%89.72B
    MRKDown 2.92%171.85B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):145.12
    P/S (ttm):5.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.92
    Quarterly EPS Est (Dec-14) :0.04
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-4.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback